193 related articles for article (PubMed ID: 16112402)
21. Vago-sympathoadrenal reflex in thermogenesis induced by osmotic stimulation of the intestines in the rat.
Osaka T; Kobayashi A; Inoue S
J Physiol; 2002 Apr; 540(Pt 2):665-71. PubMed ID: 11956352
[TBL] [Abstract][Full Text] [Related]
22. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
[TBL] [Abstract][Full Text] [Related]
23. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
Hood SG; Watson AM; May CN
Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
[TBL] [Abstract][Full Text] [Related]
24. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
Meier JJ; Holst JJ; Schmidt WE; Nauck MA
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
[TBL] [Abstract][Full Text] [Related]
25. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of the reflex inhibition of heart rate elicited by acupuncture-like stimulation in anesthetized rats.
Uchida S; Kagitani F; Hotta H
Auton Neurosci; 2008 Dec; 143(1-2):12-9. PubMed ID: 18693143
[TBL] [Abstract][Full Text] [Related]
27. Effects of central injection of glucose on thermogenesis in normal, VMH-lesioned and genetically obese rats.
Le Feuvre RA; Woods AJ; Stock MJ; Rothwell NJ
Brain Res; 1991 Apr; 547(1):110-4. PubMed ID: 1860063
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML
Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
[TBL] [Abstract][Full Text] [Related]
29. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of centrally-injected glucagon-like peptide-1 on reserpine-induced gastric mucosal lesions in rat: possible mechanisms.
Işbil Büyükcoşkun N; Güleç G; Ozlük K
Turk J Gastroenterol; 2006 Mar; 17(1):1-6. PubMed ID: 16830270
[TBL] [Abstract][Full Text] [Related]
31. Cocaine- and amphetamine-regulated transcript peptide potentiates spinal glutamatergic sympathoexcitation in anesthetized rats.
Scruggs P; Lai CC; Scruggs JE; Dun NJ
Regul Pept; 2005 Apr; 127(1-3):79-85. PubMed ID: 15680473
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
[TBL] [Abstract][Full Text] [Related]
33. Impact of maternal diabetes mellitus on the thermoregulation of the offspring.
Guimarães AF; Martins CM; Luz J
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):549-54. PubMed ID: 17177136
[TBL] [Abstract][Full Text] [Related]
34. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia.
Chance WT; Sheriff S; Dayal R; Friend LA; Thomas I; Balasubramaniam A
Peptides; 2006 Apr; 27(4):883-92. PubMed ID: 16274854
[TBL] [Abstract][Full Text] [Related]
35. The effects of centrally administered dexmedetomidine on cardiovascular and sympathetic function in conscious rats.
Shirasaka T; Qiu DL; Kannan H; Takasaki M
Anesth Analg; 2007 Dec; 105(6):1722-8, table of contents. PubMed ID: 18042874
[TBL] [Abstract][Full Text] [Related]
36. Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats.
Nakade Y; Tsukamoto K; Iwa M; Pappas TN; Takahashi T
Auton Neurosci; 2007 Jan; 131(1-2):50-6. PubMed ID: 16938493
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
[TBL] [Abstract][Full Text] [Related]
38. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
Gault VA; Hölscher C
Eur J Pharmacol; 2008 Jun; 587(1-3):112-7. PubMed ID: 18466898
[TBL] [Abstract][Full Text] [Related]
39. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
[TBL] [Abstract][Full Text] [Related]
40. Thermogenesis induced by intravenous infusion of hypertonic solutions in the rat.
Kobayashi A; Osaka T; Inoue S; Kimura S
J Physiol; 2001 Sep; 535(Pt 2):601-10. PubMed ID: 11533148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
